In 2011, he agreed to characterize Theranos, a startup that claimed to have revolutionary blood-test engineering he later on served on the company’s board. In March, 2018, the Securities and Exchange Commission billed the company’s founder with coördinating a "massive fraud" that misled investors and individuals.